Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CATX | US
0.14
1.06%
Healthcare
Medical Devices
30/06/2024
04/10/2024
13.35
13.42
13.56
13.20
Perspective Therapeutics Inc. together with its subsidiaries develops manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate brain lung head and neck gynecological pelvic/abdominal and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray Inc. and changed its name to Perspective Therapeutics Inc. in February 2022. Perspective Therapeutics Inc. was founded in 1998 and is based in Richland Washington.
View LessValue Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
66.6%1 month
69.9%3 months
72.2%6 months
80.8%-
-
2.49
-
-
-21.91
68.73
-
-47.27M
900.16M
900.16M
-
-2.71K
-
-10.50
-23.20
9.70
12.90
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
2.02
Range1M
4.43
Range3M
6.41
Rel. volume
0.32
Price X volume
4.62M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Pulse Biosciences Inc | PLSE | Medical Instruments & Supplies | 15.98 | 979.42M | -3.33% | n/a | 32.05% |
MiMedx Group Inc | MDXG | Medical Devices | 5.76 | 845.62M | -0.69% | 10.23 | 11.46% |
Embecta Corp | EMBC | Medical Instruments & Supplies | 13.51 | 779.55M | -3.08% | 11.80 | -216.41% |
Alphatec Holdings Inc | ATEC | Medical Instruments & Supplies | 5.49 | 771.13M | 4.57% | n/a | 1364.44% |
Bioventus Inc. | BVS | Medical Devices | 11.75 | 765.95M | -0.25% | n/a | 261.56% |
Cytek Biosciences Inc. Common Stock | CTKB | Medical Devices | 5.06 | 665.42M | -3.44% | n/a | 8.53% |
IRadimed Corporation | IRMD | Medical Devices | 49.82 | 631.21M | 0.50% | 33.67 | 0.47% |
OrthoPediatrics Corp | KIDS | Medical Devices | 25.93 | 627.88M | 0.23% | n/a | 3.67% |
SI-BONE Inc | SIBN | Medical Devices | 14.68 | 612.07M | 7.94% | n/a | 24.28% |
AxoGen Inc | AXGN | Medical Devices | 13.67 | 599.59M | -3.32% | n/a | 72.14% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Latham Group Inc. | SWIM | Building Products & Equipment | 6.64 | 767.43M | 0.00% | 61.27 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 24.31 | 631.67M | 2.36% | 15.15 | 2.42% |
FRP Holdings Inc | FRPH | Real Estate Services | 30.13 | 573.39M | 2.27% | 74.92 | 42.65% |
HOUS | HOUS | Real Estate Services | 5.03 | 559.70M | -5.27% | n/a | 201.36% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.25 | 502.94M | -0.19% | n/a | 174.23% |
The RMR Group Inc | RMR | Real Estate Services | 25.49 | 426.32M | 1.27% | 16.38 | 14.14% |
RE/MAX Holdings Inc | RMAX | Real Estate Services | 11.85 | 372.29M | -4.67% | n/a | 114.28% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.63 | 366.05M | 0.00% | 47.92 | 88.92% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 23.62 | 261.38M | 4.61% | 17.90 | -621.78% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 13.5 | 219.91M | 1.89% | 8.52 | 39.79% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -21.91 | 45.99 | Cheaper |
Ent. to Revenue | 68.73 | 13.20 | Expensive |
PE Ratio | - | 29.98 | - |
Price to Book | 2.49 | 6.06 | Cheaper |
Dividend Yield | - | 1.65 | - |
Std. Deviation (3M) | 72.19 | 66.08 | Par |
Debt to Equity | - | 0.83 | - |
Debt to Assets | - | 0.28 | - |
Market Cap | 900.16M | 9.42B | Emerging |